Oliver Gross Selected Research

Hereditary Nephritis (Alport Syndrome)

11/2022	Lifelong effect of therapy in young patients with the COL4A5 Alport missense variant p.(Gly624Asp): a prospective cohort study.
1/2022	Anti-microRNA-21 Therapy on Top of ACE Inhibition Delays Renal Failure in Alport Syndrome Mouse Models.
6/2021	Organoprotective Effects of Spironolactone on Top of Ramipril Therapy in a Mouse Model for Alport Syndrome.
2/2021	A glycine substitution in the collagenous domain of Col4a3 in mice recapitulates late onset Alport syndrome.
1/2021	Precise variant interpretation, phenotype ascertainment, and genotype-phenotype correlation of children in the EARLY PRO-TECT Alport trial.
1/2021	Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Hereditary Podocytopathies, Alport Syndrome, and FSGS: A Case Series to Better Plan a Large-Scale Study.
1/2020	A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome.
1/2020	The importance of clinician, patient and researcher collaborations in Alport syndrome.
1/2020	Clinical trial recommendations for potential Alport syndrome therapies.
1/2019	Expert consensus guidelines for the genetic diagnosis of Alport syndrome.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Oliver Gross Research Topics

Disease

35	Hereditary Nephritis (Alport Syndrome) 11/2022 - 04/2000
25	Proteinuria 01/2022 - 02/2003
20	Fibrosis (Cirrhosis) 01/2022 - 02/2003
15	Renal Insufficiency (Renal Failure) 11/2022 - 02/2003
13	Chronic Kidney Failure (Chronic Renal Failure) 11/2022 - 02/2003
8	Inflammation (Inflammations) 01/2021 - 08/2005
6	Chronic Renal Insufficiency 01/2021 - 07/2004
6	Inborn Genetic Diseases (Disease, Hereditary) 01/2020 - 04/2000
6	Kidney Diseases (Kidney Disease) 01/2019 - 01/2012
6	Hearing Loss (Hearing Impairment) 06/2017 - 04/2000
4	Disease Progression 01/2020 - 04/2010
3	Hypertension (High Blood Pressure) 01/2019 - 08/2005
3	Hematuria 04/2012 - 07/2006
3	Nephritis 12/2010 - 04/2000
2	COVID-19 01/2021 - 01/2021
2	Hypoxia (Hypoxemia) 01/2021 - 01/2011
2	Glomerulonephritis 01/2021 - 10/2014
2	IGA Glomerulonephritis (IGA Nephropathy) 01/2018 - 04/2010
2	Uremia 01/2017 - 07/2004
2	Dyslipidemias (Dyslipidemia) 09/2014 - 09/2009
2	Atrophy 04/2010 - 04/2005
1	Hyperkalemia 06/2021
1	Hypoalbuminemia 01/2021
1	Hemorrhage 01/2021
1	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 01/2021
1	Albuminuria 01/2020
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 02/2019
1	Rupture 01/2019
1	Ureteral Obstruction 01/2019
1	Segmental glomerulosclerosis 01/2019
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2018
1	Hypercholesterolemia 08/2017
1	Hyperlipidemias (Hyperlipidemia) 08/2017
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 08/2017
1	Dysbiosis 01/2017

Drug/Important Bio-Agent (IBA)

16	Collagen Type IV (Type IV Collagen)IBA 02/2021 - 04/2000
10	Urea (Carbamide)FDA LinkGeneric 02/2021 - 02/2003
9	CollagenIBA 01/2021 - 09/2009
7	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2022 - 07/2004
7	CreatinineIBA 02/2021 - 06/2003
6	Ramipril (Altace)FDA LinkGeneric 06/2021 - 02/2003
6	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021 - 03/2012
5	Pharmaceutical PreparationsIBA 06/2017 - 02/2010
5	Collagen ReceptorsIBA 09/2014 - 12/2005
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2017 - 12/2005
4	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2014 - 02/2010
3	NitrogenIBA 01/2019 - 06/2010
3	Proteins (Proteins, Gene)FDA Link 12/2015 - 01/2011
3	CytokinesIBA 01/2012 - 08/2005
2	AntibodiesIBA 01/2021 - 01/2019
2	NPHS2 proteinIBA 01/2019 - 01/2012
2	nephrinIBA 01/2019 - 01/2012
2	AlbuminsIBA 01/2018 - 08/2017
2	EndotoxinsIBA 01/2017 - 01/2011
2	Biomarkers (Surrogate Marker)IBA 12/2015 - 11/2013
2	paricalcitol (Zemplar)FDA Link 09/2014 - 05/2014
2	Discoidin Domain Receptor 1IBA 02/2014 - 06/2010
2	Connective Tissue Growth FactorIBA 03/2011 - 07/2006
2	Antihypertensive Agents (Antihypertensives)IBA 03/2011 - 08/2005
2	Transforming Growth Factor beta (TGF-beta)IBA 08/2010 - 07/2006
2	AutoantibodiesIBA 06/2009 - 02/2007
2	Vasopeptidase InhibitorsIBA 12/2005 - 08/2005
1	Mineralocorticoid Receptor AntagonistsIBA 06/2021
1	Spironolactone (Aldactone)FDA LinkGeneric 06/2021
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 02/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Erythropoietin FDA Link 01/2021
1	DiureticsIBA 01/2021
1	Heparin (Liquaemin)FDA LinkGeneric 01/2021
1	SodiumIBA 01/2021
1	Serum AlbuminIBA 01/2021
1	Antithrombin IIIIBA 01/2021
1	eculizumab FDA Link 01/2021
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Biological ProductsIBA 01/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	Prednisone (Sone)FDA LinkGeneric 02/2019
1	Abiraterone AcetateIBA 02/2019
1	abirateroneIBA 02/2019
1	Angiotensin IIIBA 01/2019
1	platelet-derived growth factor C (PDGF-C)IBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	Prednisolone (Predate)FDA LinkGeneric 01/2018
1	C-Reactive ProteinIBA 01/2018
1	Azathioprine (Imuran)FDA LinkGeneric 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 08/2017
1	Lipoprotein(a)IBA 08/2017
1	Ezetimibe (Zetia)FDA Link 08/2017

Therapy/Procedure

25	Therapeutics 11/2022 - 02/2003
5	Renal Replacement Therapy (Therapies, Renal Replacement) 11/2022 - 04/2012
2	Secondary Prevention 11/2022 - 02/2003
2	Kidney Transplantation 12/2012 - 05/2009
1	Critical Care (Surgical Intensive Care) 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Drug Therapy (Chemotherapy) 01/2018